title: Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Lotke
authors.forename: John J
authors.initials: JJ
authors.lastname: Callaghan
authors.forename: Lawrence D
authors.initials: LD
authors.lastname: Dorr
authors.forename: Gerard H
authors.initials: GH
authors.lastname: Engh
authors.forename: Arlen D
authors.initials: AD
authors.lastname: Hanssen
authors.forename: William L
authors.initials: WL
authors.lastname: Healy
authors.forename: Paul F
authors.initials: PF
authors.lastname: Lachiewicz
authors.forename: Jess H
authors.initials: JH
authors.lastname: Lonner
authors.forename: Charles
authors.initials: C
authors.lastname: Nelson
authors.forename: Chitranjan S
authors.initials: CS
authors.lastname: Ranawat
authors.forename: Merrill A
authors.initials: MA
authors.lastname: Ritter
authors.forename: Eduardo A
authors.initials: EA
authors.lastname: Salvati
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Sculco
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Thornhill
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D017211:Treatment Failure; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D014859:Warfarin